Ferry Ossendorp

18.0k total citations · 3 hit papers
228 papers, 13.7k citations indexed

About

Ferry Ossendorp is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ferry Ossendorp has authored 228 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 184 papers in Immunology, 91 papers in Molecular Biology and 58 papers in Oncology. Recurrent topics in Ferry Ossendorp's work include Immunotherapy and Immune Responses (156 papers), T-cell and B-cell Immunology (55 papers) and Immune Cell Function and Interaction (51 papers). Ferry Ossendorp is often cited by papers focused on Immunotherapy and Immune Responses (156 papers), T-cell and B-cell Immunology (55 papers) and Immune Cell Function and Interaction (51 papers). Ferry Ossendorp collaborates with scholars based in Netherlands, United States and Germany. Ferry Ossendorp's co-authors include Cornelis J.M. Melief, Sjoerd H. van der Burg, Thorbald van Hall, Ramon Arens, Marcel Camps, Luis J. Cruz, Marieke F. Fransen, René E. M. Toes, Wim Jiskoot and Rienk Offringa and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ferry Ossendorp

225 papers receiving 13.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic cancer vaccines

2015 972 citations Cornelis J.M. Melief, Thorbald van Hall et al. profile →
Vaccines for established cancer: overcoming the challenges posed by immune evasion

2016 557 citations Sjoerd H. van der Burg, Ramon Arens et al. profile →
Current Challenges and Opportunities of Photodynamic Therapy against Cancer

2023 102 citations Luis J. Cruz, Ferry Ossendorp et al. Pharmaceutics profile →

Peers

Countries citing papers authored by Ferry Ossendorp

Since Specialization

Citations

This map shows the geographic impact of Ferry Ossendorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferry Ossendorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferry Ossendorp more than expected).

Fields of papers citing papers by Ferry Ossendorp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferry Ossendorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferry Ossendorp. The network helps show where Ferry Ossendorp may publish in the future.

Co-authorship network of co-authors of Ferry Ossendorp

This figure shows the co-authorship network connecting the top 25 collaborators of Ferry Ossendorp. A scholar is included among the top collaborators of Ferry Ossendorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferry Ossendorp. Ferry Ossendorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control 2022 ·npj Vaccines ·Elena Tondini, (unknown), (unknown), Tsolère Arakelian, (unknown), Marcel Camps, (unknown), Gijs A. van der Marel, Dmitri V. Filippov, Jeroen D. C. Codée, Ferry Ossendorp	9
2	Combinatorial Therapeutic Approaches with Nanomaterial-Based Photodynamic Cancer Therapy 2022 ·Pharmaceutics ·Hao Yang, Chih Kit Chung, Zhenfeng Yu, (unknown), Ferry Ossendorp, Peter ten Dijke, Luis J. Cruz	43
3	Bioorthogonal protein labelling enables the study of antigen processing of citrullinated and carbamylated auto-antigens 2021 ·RSC Chemical Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marcel Camps, George M. C. Janssen, Peter A. van Veelen, Gerard J. P. van Westen, Antonius P. A. Janssen, Bogdan I. Florea, Herman S. Overkleeft, Ferry Ossendorp, René E. M. Toes, Sander I. van Kasteren	6
4	Zinc-Phthalocyanine-Loaded Extracellular Vesicles Increase Efficacy and Selectivity of Photodynamic Therapy in Co-Culture and Preclinical Models of Colon Cancer 2021 ·Pharmaceutics ·Pablo Lara, (unknown), (unknown), Alan Chan, Ferry Ossendorp, Luis J. Cruz	22
5	Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights 2021 ·International Journal of Molecular Sciences ·Marieke F. Fransen, Thorbald van Hall, Ferry Ossendorp	25
6	Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and Cytosplore 2019 ·Journal of Visualized Experiments ·(unknown), (unknown), Ferry Ossendorp, Ramon Arens	0
7	A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control 2019 ·OncoImmunology ·Elena Tondini, Tsolère Arakelian, Koen Oosterhuis, Marcel Camps, Suzanne van Duikeren, Wanda G. H. Han, Ramon Arens, Gerben Zondag, Jeroen van Bergen, Ferry Ossendorp	52
8	Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer 2019 ·OncoImmunology ·(unknown), Marcel Camps, Jitske van den Bulk, Elena Tondini, (unknown), Dina Ruano, Kees L. M. C. Franken, George M. C. Janssen, Arnoud H. de Ru, Dmitri V. Filippov, Ramon Arens, Peter A. van Veelen, Noel F.C.C. de Miranda, Ferry Ossendorp	56
9	Chemical Control over T-Cell Activation in Vivo Using Deprotection of trans-Cyclooctene-Modified Epitopes 2018 ·ACS Chemical Biology ·(unknown), (unknown), Marcel Camps, Tracy J. Ruckwardt, (unknown), (unknown), Elmer Maurits, Joanna B. Pawlak, (unknown), Kimberly M. Bonger, Dmitri V. Filippov, Herman S. Overkleeft, Marc S. Robillard, Ferry Ossendorp, Sander I. van Kasteren	34
10	High FcγR Expression on Intratumoral Macrophages Enhances Tumor-Targeting Antibody Therapy 2018 ·The Journal of Immunology ·(unknown), (unknown), Cor Breukel, Jill Claassens, Conny Brouwers, Margot M. Linssen, Marieke F. Fransen, Marjolein Sluijter, Ferry Ossendorp, Thorbald van Hall, J. Sjef Verbeek	7
11	Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy 2018 ·JCI Insight ·Marieke F. Fransen, Mark J.A. Schoonderwoerd, Philipp Knopf, Marcel Camps, Lukas J.A.C. Hawinkels, Manfred Kneilling, Thorbald van Hall, Ferry Ossendorp	265
12	Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide Vaccines 2017 ·Cancer Immunology Research ·Eleni Maria Varypataki, Naomi Benne, Joke A. Bouwstra, Wim Jiskoot, Ferry Ossendorp	57
13	CD4+ T Cell and NK Cell Interplay Key to Regression of MHC Class Ilow Tumors upon TLR7/8 Agonist Therapy 2017 ·Cancer Immunology Research ·Elien M. Doorduijn, Marjolein Sluijter, Daniela Salvatori, (unknown), Saskia Maas, Ramon Arens, Ferry Ossendorp, Sjoerd H. van der Burg, Thorbald van Hall	36
14	Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination 2017 ·Molecular Pharmaceutics ·Mazda Rad‐Malekshahi, Marieke F. Fransen, Małgorzata Krawczyk, Mercedeh Mansourian, Meriem Bourajjaj, Jian Chen, Ferry Ossendorp, Wim E. Hennink, Enrico Mastrobattista, Maryam Amidi	47
15	Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors 2015 ·Clinical Cancer Research ·Jan Willem Kleinovink, (unknown), Thomas J. Snoeks, (unknown), Marieke F. Fransen, Luis J. Cruz, Laura Mezzanotte, Alan Chan, Clemens W.G.M. Löwik, Ferry Ossendorp	96
16	Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death 2014 ·Clinical Cancer Research ·Tetje C. van der Sluis, Suzanne van Duikeren, (unknown), Ekaterina S. Jordanova, Elham Beyranvand Nejad, (unknown), Louis Boon, Vincent T.H.B.M. Smit, Marij J.P. Welters, Ferry Ossendorp, Bob van de Water, Ramon Arens, Sjoerd H. van der Burg, Cornelis J.M. Melief	60
17	Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates 2014 ·Cancer Immunology Research ·Gijs G. Zom, Selina Khan, Cedrik M. Britten, (unknown), Marcel Camps, Nikki M. Loof, (unknown), Nico J. Meeuwenoord, Dmitri V. Filippov, Gijsbert A. van der Marel, Herman S. Overkleeft, Cornelis J.M. Melief, Ferry Ossendorp	81
18	Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects 2013 ·Clinical Cancer Research ·Marieke F. Fransen, Tetje C. van der Sluis, Ferry Ossendorp, Ramon Arens, Cornelis J.M. Melief	159
19	Direct Evidence for a Primary Immune Response of Murine B-Lymphocytes After In Vitro Immunization of Dissociated Splenocytes 1987 ·Hybridoma ·Mark de Boer, Ferry Ossendorp, Peter F. Bruning, J. M. Tager	10
20	Characterization of Five Monoclonal Antibodies Obtained After Immunization In Vitro with a Synthetic 19-Amino Acid Peptide of Thyroglobulin 1987 ·Hybridoma ·Mark de Boer, Peter J.J. Admiraal, Kasper Kok, Ferry Ossendorp, Jan J. M. de Vijlder, J. M. Tager	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact